Expert Discusses: Can Immunotherapy Be Successful in Prostate Cancer?
April 10th 2017While other tumor types have seen extraordinary progress with immunotherapy agents such as Opdivo (nivolumab) and Yervoy (ipilimumab), they have not yet shown similar success in the treatment of prostate cancer. Padmanee Sharma, M.D., Ph.D., weighs in.
Read More